Advagene Biopharma Co Ltd

NEW
ROCO:6709 (Taiwan)   Ordinary Shares
NT$ 24.45 +0.65 (+2.73%) Sep 15
At Loss
P/B:
4.76
Market Cap:
NT$ 1.70B ($ 53.34M)
Enterprise V:
NT$ 1.37B ($ 43.23M)
Volume:
6.10K
Avg Vol (2M):
63.47K
Trade In:
Volume:
6.10K
At Loss
Avg Vol (2M):
63.47K

Advagene Biopharma Co Ltd (ROCO:6709) Dividend

Advagene Biopharma Co Ltd (ROCO:6709) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:6709 Dividend

Does Advagene Biopharma Co Ltd (ROCO:6709) pay a dividend?

Advagene Biopharma Co Ltd (ROCO:6709) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Advagene Biopharma Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Advagene Biopharma Co Ltd has returned capital to shareholders via buybacks at a rate of -6% over the past 3 years.

What are dividend-paying alternatives to Advagene Biopharma Co Ltd?

For dividend-paying alternatives in Advagene Biopharma Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.